Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wang, 2007, The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis, Epidemiol Rev, 29, 6, 10.1093/epirev/mxm007
2006, State-specific prevalence of obesity among adults—United States, 2005, MMWR Morb Mortal Wkly Rep, 55, 985
Wang, 2011, Health and economic burden of the projected obesity trends in the USA and the UK, Lancet, 378, 815, 10.1016/S0140-6736(11)60814-3
Finkelstein, 2009, Annual medical spending attributable to obesity: payer- and service-specific estimates, Health Aff (Millwood), 28, w822, 10.1377/hlthaff.28.5.w822
World Cancer Research Fund/American Institute for Cancer Research, 2007, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective
Suzuki, 2009, Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis, Int J Cancer, 124, 698, 10.1002/ijc.23943
Renehan, 2008, Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies, Lancet, 371, 569, 10.1016/S0140-6736(08)60269-X
Vrieling, 2010, Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis, Breast Cancer Res Treat, 123, 641, 10.1007/s10549-010-1116-4
Althuis, 2004, Etiology of hormone receptor-defined breast cancer: a systematic review of the literature, Cancer Epidemiol Biomarkers Prev, 13, 1558, 10.1158/1055-9965.1558.13.10
Phipps, 2008, Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women, Cancer Epidemiol Biomarkers Prev, 17, 2078, 10.1158/1055-9965.EPI-08-0206
Phipps, 2011, Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer, Cancer Epidemiol Biomarkers Prev, 20, 454, 10.1158/1055-9965.EPI-10-0974
Huang, 1997, Dual effects of weight and weight gain on breast cancer risk, JAMA, 278, 1407, 10.1001/jama.1997.03550170037029
Trentham-Dietz, 2000, Weight change and risk of postmenopausal breast cancer (United States), Cancer Causes Control, 11, 533, 10.1023/A:1008961931534
Franceschi, 1996, Body size indices and breast cancer risk before and after menopause, Int J Cancer, 67, 181, 10.1002/(SICI)1097-0215(19960717)67:2<181::AID-IJC5>3.0.CO;2-P
Magnusson, 1998, Body size in different periods of life and breast cancer risk in post-menopausal women, Int J Cancer, 76, 29, 10.1002/(SICI)1097-0215(19980330)76:1<29::AID-IJC6>3.0.CO;2-#
Feigelson, 2004, Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study, Cancer Epidemiol Biomarkers Prev, 13, 220, 10.1158/1055-9965.EPI-03-0301
Friedenreich, 2002, Case-control study of anthropometric measures and breast cancer risk, Int J Cancer, 99, 445, 10.1002/ijc.10389
Lahmann, 2004, Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC), Int J Cancer, 111, 762, 10.1002/ijc.20315
Li, 2006, Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States), Cancer Causes Control, 17, 695, 10.1007/s10552-005-0001-7
Wu, 2007, Body size, hormone therapy and risk of breast cancer in Asian-American women, Int J Cancer, 120, 844, 10.1002/ijc.22387
Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results. From the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321
Anderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001/jama.291.14.1701
2000, Obesity: preventing and managing the global epidemic. Report of a WHO consultation, World Health Organ Tech Rep Ser, 894:i–xii, 1
DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2
Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446
Sterne, 2001, Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis, J Clin Epidemiol, 54, 1046, 10.1016/S0895-4356(01)00377-8
Sterne, 2001, Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis, BMJ, 323, 101, 10.1136/bmj.323.7304.101
Sterne, 2000, Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature, J Clin Epidemiol, 53, 1119, 10.1016/S0895-4356(00)00242-0
Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629
Newcomb, 2002, Postmenopausal estrogen and progestin use in relation to breast cancer risk, Cancer Epidemiol Biomarkers Prev, 11, 593
Saxena, 2010, Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study, Cancer Epidemiol Biomarkers Prev, 19, 2366, 10.1158/1055-9965.EPI-10-0162
Rosenberg, 2006, Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study, Breast Cancer Res, 8, R11, 10.1186/bcr1378
Chlebowski, 2003, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial, JAMA, 289, 3243, 10.1001/jama.289.24.3243
Reeves, 2007, Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study, BMJ, 335, 1134, 10.1136/bmj.39367.495995.AE
Yang, 2011, Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies, J Natl Cancer Inst, 103, 250, 10.1093/jnci/djq526
Pierobon, 2013, Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis, Breast Cancer Res Treat, 137, 307, 10.1007/s10549-012-2339-3
Eliassen, 2006, Adult weight change and risk of postmenopausal breast cancer, JAMA, 296, 193, 10.1001/jama.296.2.193
London, 1989, Prospective study of relative weight, height, and risk of breast cancer, JAMA, 262, 2853, 10.1001/jama.1989.03430200097033
Harvie, 2005, Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa Women's Health Study, Cancer Epidemiol Biomarkers Prev, 14, 656, 10.1158/1055-9965.EPI-04-0001
Macinnis, 2004, Body size and composition and risk of postmenopausal breast cancer, Cancer Epidemiol Biomarkers Prev, 13, 2117, 10.1158/1055-9965.2117.13.12
Harvie, 2003, Central obesity and breast cancer risk: a systematic review, Obes Rev, 4, 157, 10.1046/j.1467-789X.2003.00108.x
Schapira, 1990, Abdominal obesity and breast cancer risk, Ann Intern Med, 112, 182, 10.7326/0003-4819-112-3-182
Connolly, 2002, A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer, Nutr Cancer, 44, 127, 10.1207/S15327914NC4402_02
Mannisto, 1996, Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status, Int J Cancer, 68, 8, 10.1002/(SICI)1097-0215(19960927)68:1<8::AID-IJC2>3.0.CO;2-V
Huang, 1999, Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses’ Health Study, Am J Epidemiol, 150, 1316, 10.1093/oxfordjournals.aje.a009963
Sexton, 2011, A review of body size and breast cancer risk in Hispanic and African American women, Cancer, 117, 5271, 10.1002/cncr.26217
Gilliland, 1998, Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women's Health Study, Am J Epidemiol, 148, 683, 10.1093/aje/148.7.683
Wenten, 2002, Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women, Ann Epidemiol, 12, 435, 10.1016/S1047-2797(01)00293-9
Slattery, 2007, Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women, Breast Cancer Res Treat, 102, 85, 10.1007/s10549-006-9292-y
Collaborative Group on Hormonal Factors in Breast Cancer, 1997, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer, Lancet, 350, 1047, 10.1016/S0140-6736(97)08233-0
Hulley, 2002, Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II), JAMA, 288, 58, 10.1001/jama.288.1.58
Buist, 2004, Hormone therapy prescribing patterns in the United States, Obstet Gynecol, 104, 1042, 10.1097/01.AOG.0000143826.38439.af
Clarke, 2006, Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence, J Clin Oncol, 24, 49, 10.1200/JCO.2006.08.6504
Haas, 2004, Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results, Ann Intern Med, 140, 184, 10.7326/0003-4819-140-3-200402030-00009
Kerlikowske, 2007, Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population, J Natl Cancer Inst, 99, 1335, 10.1093/jnci/djm111
Hersh, 2004, National use of postmenopausal hormone therapy: annual trends and response to recent evidence, JAMA, 291, 47, 10.1001/jama.291.1.47
Ravdin, 2007, The decrease in breast-cancer incidence in 2003 in the United States, N Engl J Med, 356, 1670, 10.1056/NEJMsr070105
Chlebowski, 2010, Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women, JAMA, 304, 1684, 10.1001/jama.2010.1500
Sprague, 2012, A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999–2010, Obstet Gynecol, 120, 595, 10.1097/AOG.0b013e318265df42
Nelson, 2012, Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations, Ann Intern Med, 157, 104, 10.7326/0003-4819-157-2-201207170-00466
Morimoto, 2002, Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States), Cancer Causes Control, 13, 741, 10.1023/A:1020239211145
van den Brandt, 2000, Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk, Am J Epidemiol, 152, 514, 10.1093/aje/152.6.514
Ursin, 2002, Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?, J Clin Oncol, 20, 699, 10.1200/JCO.2002.20.3.699
Rosenberg, 2006, A prospective study of female hormone use and breast cancer among black women, Arch Intern Med, 166, 760, 10.1001/archinte.166.7.760
Brinton, 2008, Menopausal hormone therapy and breast cancer risk in the NIH–AARP Diet and Health Study Cohort, Cancer Epidemiol Biomarkers Prev, 17, 3150, 10.1158/1055-9965.EPI-08-0435
Gertig, 2006, Hormone therapy and breast cancer: what factors modify the association?, Menopause, 13, 178, 10.1097/01.gme.0000177317.85887.65
Harris, 1992, Breast cancer risk: effects of estrogen replacement therapy and body mass, J Natl Cancer Inst, 84, 1575, 10.1093/jnci/84.20.1575
Shantakumar, 2007, Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk, Am J Epidemiol, 165, 1187, 10.1093/aje/kwm006
Vacek, 2004, A prospective study of breast cancer risk using routine mammographic breast density measurements, Cancer Epidemiol Biomarkers Prev, 13, 715, 10.1158/1055-9965.715.13.5
Anderson, 2012, Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial, Lancet Oncol, 13, 476, 10.1016/S1470-2045(12)70075-X
Davis, 1994, The weights and heights of Mexican-American adolescents: the accuracy of self-reports, Am J Public Health, 84, 459, 10.2105/AJPH.84.3.459
Kushi, 1988, Accuracy and reliability of self-measurement of body girths, Am J Epidemiol, 128, 740, 10.1093/oxfordjournals.aje.a115027
Must, 1993, Remote recall of childhood height, weight, and body build by elderly subjects, Am J Epidemiol, 138, 56, 10.1093/oxfordjournals.aje.a116777
Rimm, 1990, Validity of self-reported waist and hip circumferences in men and women, Epidemiology, 1, 466, 10.1097/00001648-199011000-00009
Stewart, 1982, The reliability and validity of self-reported weight and height, J Chronic Dis, 35, 295, 10.1016/0021-9681(82)90085-6
Stunkard, 1981, The accuracy of self-reported weights, Am J Clin Nutr, 34, 1593, 10.1093/ajcn/34.8.1593
Goodman, 1990, Agreement between interview information and physician records on history of menopausal estrogen use, Am J Epidemiol, 131, 815, 10.1093/oxfordjournals.aje.a115572
Greendale, 1997, Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI investigators, Am J Epidemiol, 146, 763, 10.1093/oxfordjournals.aje.a009352
Jain, 1999, Agreement of self-reported use of menopausal hormone replacement therapy with physician reports, Epidemiology, 10, 260, 10.1097/00001648-199905000-00012
Jannausch, 1992, Consistency of perimenopausal estrogen use reporting by women in a population-based prospective study, Maturitas, 14, 161, 10.1016/0378-5122(92)90111-G
Calle, 2004, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat Rev Cancer, 4, 579, 10.1038/nrc1408
Key, 2002, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J Natl Cancer Inst, 94, 606, 10.1093/jnci/94.8.606
Eliassen, 2012, Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women, Cancer Res, 72, 696, 10.1158/0008-5472.CAN-11-2507
Potischman, 1996, Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status, J Natl Cancer Inst, 88, 756, 10.1093/jnci/88.11.756
Rich-Edwards, 1994, Adolescent body mass index and infertility caused by ovulatory disorder, Am J Obstet Gynecol, 171, 171, 10.1016/0002-9378(94)90465-0
Siiteri, 1987, Adipose tissue as a source of hormones, Am J Clin Nutr, 45, 277, 10.1093/ajcn/45.1.277
Key, 2003, Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women, J Natl Cancer Inst, 95, 1218, 10.1093/jnci/djg022
Renehan, 2006, Obesity and cancer risk: the role of the insulin-IGF axis, Trends Endocrinol Metab, 17, 328, 10.1016/j.tem.2006.08.006
Rose, 2004, Obesity, adipocytokines, and insulin resistance in breast cancer, Obes Rev, 5, 153, 10.1111/j.1467-789X.2004.00142.x
Interagency Breast Cancer and the Environment Research Coordinating Committee, 2013
Ahn, 2007, Adiposity, adult weight change, and postmenopausal breast cancer risk, Arch Intern Med, 167, 2091, 10.1001/archinte.167.19.2091
Barlow, 2006, Prospective breast cancer risk prediction model for women undergoing screening mammography, J Natl Cancer Inst, 98, 1204, 10.1093/jnci/djj331
Barnes, 2011, Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors, Cancer Epidemiol, 35, 345, 10.1016/j.canep.2010.11.003
Berstad, 2010, A case-control study of body mass index and breast cancer risk in white and African-American women, Cancer Epidemiol Biomarkers Prev, 19, 1532, 10.1158/1055-9965.EPI-10-0025
Boyd, 2006, Body size, mammographic density, and breast cancer risk, Cancer Epidemiol Biomarkers Prev, 15, 2086, 10.1158/1055-9965.EPI-06-0345
Cerne, 2011, Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women, Climacteric, 14, 458, 10.3109/13697137.2010.541307
Chang, 2006, Association of energy intake and energy balance with postmenopausal breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, Cancer Epidemiol Biomarkers Prev, 15, 334, 10.1158/1055-9965.EPI-05-0479
Chlebowski, 2007, Predicting risk of breast cancer in postmenopausal women by hormone receptor status, J Natl Cancer Inst, 99, 1695, 10.1093/jnci/djm224
Cotterchio, 2003, Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup, Cancer Epidemiol Biomarkers Prev, 12, 1053
Cust, 2009, The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study, Breast Cancer Res Treat, 113, 567, 10.1007/s10549-008-9958-8
Eng, 2005, Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York, Am J Epidemiol, 162, 229, 10.1093/aje/kwi195
Gaudet, 2010, Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?, Cancer Epidemiol, 34, 580, 10.1016/j.canep.2010.05.014
Hall, 2000, Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study, Am J Epidemiol, 151, 754, 10.1093/oxfordjournals.aje.a010275
Harlid, 2012, Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer, BMC Womens Health, 12
Hines, 2010, Comparative analysis of breast cancer risk factors among Hispanic and non-Hispanic white women, Cancer, 116, 3215, 10.1002/cncr.25154
Hislop, 1986, Relationship between risk factors for breast cancer and hormonal status, Int J Epidemiol, 15, 469, 10.1093/ije/15.4.469
Huang, 2000, Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status, Am J Epidemiol, 151, 703, 10.1093/oxfordjournals.aje.a010265
John, 2003, Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study, Cancer Epidemiol Biomarkers Prev, 12, 1143
John, 2011, Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study, Am J Epidemiol, 173, 201, 10.1093/aje/kwq345
Jumaan, 1999, Beta-carotene intake and risk of postmenopausal breast cancer, Epidemiology, 10, 49, 10.1097/00001648-199901000-00009
Krebs, 2006, Measures of adiposity and risk of breast cancer in older postmenopausal women, J Am Geriatr Soc, 54, 63, 10.1111/j.1532-5415.2005.00541.x
Li, 2000, Anthropometric variables in relation to risk of breast cancer in middle-aged women, Int J Epidemiol, 29, 208, 10.1093/ije/29.2.208
Ma, 2006, Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison, Breast Cancer Res, 8, R39, 10.1186/bcr1514
Meier, 2002, Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer, Pharmacotherapy, 22, 303, 10.1592/phco.22.5.303.33189
Michels, 2006, Longitudinal study on the role of body size in premenopausal breast cancer, Arch Intern Med, 166, 2395, 10.1001/archinte.166.21.2395
Modugno, 2006, Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer, Int J Cancer, 118, 1292, 10.1002/ijc.21487
Nemesure, 2009, Body size and breast cancer in a black population—the Barbados National Cancer Study, Cancer Causes Control, 20, 387, 10.1007/s10552-008-9253-3
Obi, 2009, The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study, Cancer Epidemiol Biomarkers Prev, 18, 2207, 10.1158/1055-9965.EPI-09-0298
Palmer, 2007, A prospective study of body size and breast cancer in black women, Cancer Epidemiol Biomarkers Prev, 16, 1795, 10.1158/1055-9965.EPI-07-0336
Pan, 2004, Association of obesity and cancer risk in Canada, Am J Epidemiol, 159, 259, 10.1093/aje/kwh041
Peacock, 1999, Relation between obesity and breast cancer in young women, Am J Epidemiol, 149, 339, 10.1093/oxfordjournals.aje.a009818
Rinaldi, 2006, Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort, Int J Cancer, 118, 2832, 10.1002/ijc.21730
Rosenberg, 2006, Risk factors for hormone receptor-defined breast cancer in postmenopausal women, Cancer Epidemiol Biomarkers Prev, 15, 2482, 10.1158/1055-9965.EPI-06-0489
Sarkissyan, 2011, Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles, Cancer, 117, 3814, 10.1002/cncr.25956
Silvera, 2006, Energy balance and breast cancer risk: a prospective cohort study, Breast Cancer Res Treat, 97, 97, 10.1007/s10549-005-9098-3
Suzuki, 2006, Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study, Int J Cancer, 119, 1683, 10.1002/ijc.22034
Swanson, 1989, Body size and breast cancer risk assessed in women participating in the Breast Cancer Detection Demonstration Project, Am J Epidemiol, 130, 1133, 10.1093/oxfordjournals.aje.a115440
Swanson, 1996, Body size and breast cancer risk among women under age 45 years, Am J Epidemiol, 143, 698, 10.1093/oxfordjournals.aje.a008803
Sweeney, 2004, Risk factors for breast cancer in elderly women, Am J Epidemiol, 160, 868, 10.1093/aje/kwh276
Toniolo, 1994, Consumption of meat, animal products, protein, and fat and risk of breast cancer: a prospective cohort study in New York, Epidemiology, 5, 391, 10.1097/00001648-199407000-00003
Tornberg, 1994, Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years, Br J Cancer, 69, 358, 10.1038/bjc.1994.65
Trentham-Dietz, 1997, Body size and risk of breast cancer, Am J Epidemiol, 145, 1011, 10.1093/oxfordjournals.aje.a009057
van den Brandt, 1997, Height, weight, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study, Cancer Causes Control, 8, 39, 10.1023/A:1018479020716
Vatten, 1992, Prospective study of height, body mass index and risk of breast cancer, Acta Oncol, 31, 195, 10.3109/02841869209088902
Weiderpass, 2004, A prospective study of body size in different periods of life and risk of premenopausal breast cancer, Cancer Epidemiol Biomarkers Prev, 13, 1121, 10.1158/1055-9965.1121.13.7
White, 2012, Body size and breast cancer risk: the Multiethnic Cohort, Int J Cancer, 131, E705, 10.1002/ijc.27373
Zhu, 2005, Body mass index and breast cancer risk in African American women, Ann Epidemiol, 15, 123, 10.1016/j.annepidem.2004.05.011
Bakken, 2011, Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition, Int J Cancer, 128, 144, 10.1002/ijc.25314
Beral, 2011, Breast cancer risk in relation to the interval between menopause and starting hormone therapy, J Natl Cancer Inst, 103, 296, 10.1093/jnci/djq527
Chen, 2002, Hormone replacement therapy in relation to breast cancer, JAMA, 287, 734, 10.1001/jama.287.6.734
Chen, 2004, Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma, Cancer, 101, 1490, 10.1002/cncr.20499
Ewertz, 2005, Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study, Br J Cancer, 92, 1293, 10.1038/sj.bjc.6602472
Fournier, 2005, Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, Int J Cancer, 114, 448, 10.1002/ijc.20710
Fournier, 2008, Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer, J Clin Oncol, 26, 1260, 10.1200/JCO.2007.13.4338
Kotsopoulos, 2009, +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer, Int J Cancer, 125, 1685, 10.1002/ijc.24477
Lee, 2006, Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort, Int J Cancer, 118, 1285, 10.1002/ijc.21481
Li, 2000, Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women, Cancer, 88, 2570, 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O
Li, 2008, Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas, Cancer Epidemiol Biomarkers Prev, 17, 43, 10.1158/1055-9965.EPI-07-0558
Lyytinen, 2010, A case-control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well, Int J Cancer, 126, 483, 10.1002/ijc.24738
Newcomb, 1995, Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women, Am J Epidemiol, 142, 788, 10.1093/oxfordjournals.aje.a117717
Opatrny, 2008, Hormone replacement therapy use and variations in the risk of breast cancer, BJOG, 115, 169, 10.1111/j.1471-0528.2007.01520.x
Persson, 1999, Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement, Cancer Causes Control, 10, 253, 10.1023/A:1008909128110
Reding, 2012, Estrogen-related genes and their contribution to racial differences in breast cancer risk, Cancer Causes Control, 23, 671, 10.1007/s10552-012-9925-x
Schairer, 1994, Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States), Cancer Causes Control, 5, 491, 10.1007/BF01831376
Sprague, 2008, Proportion of invasive breast cancer attributable to risk factors modifiable after menopause, Am J Epidemiol, 168, 404, 10.1093/aje/kwn143
Stahlberg, 2004, Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy, Br J Cancer, 91, 644, 10.1038/sj.bjc.6601996
Weiss, 2002, Hormone replacement therapy regimens and breast cancer risk(1), Obstet Gynecol, 100, 1148